(E)-4-(Prop-1-en-2-yl)cyclohex-1-enecarbaldehyde oxime, 98.0%, 10g

8-Benzyl-3-methyl-8-azabicyclo[3.2.1]octan-3-ol, 98%, 1g

(3R,4R,5R)-3,4-bis(benzyloxy)-5-((benzyloxy)methyl)tetrahydrofuran-2-ol, 98%, 250mg

5',6',7',8'-tetrahydro-3'H-spiro[cyclohexane-1,4'-quinazoline]-2'-thiol, 100mg

Bianthrone>95.0%(HPLC)1g

4,5-Dichlorothiophene-2-carboxylic acid, 95.0%, 100g

HMBA Linker, 98%, 100g

5,6-Dichloro-2,3-dicyanopyrazine, 98.0%, 5g

5-(4-Chloro-3-(trifluoromethyl)phenyl)oxazole, 98%, 1g

1-Iodoimidazo[1,5-a]pyridine, 95%, 1g

2,2'-Methylenebis[6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetamethylbuty)phenol], 98.0%, 10g

1,2-BIS(BROMOMETHYL)-4,5-DIMETHOXYBENZENE, 95.0%, 1g

N-Benzyl-3,4-dinitrobenzamide, 1g